Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety of Hemay005 Tablets in Multiple Doses and Different Administration Methods in Multiple Administrations for Chinese Adult Healthy Subjects in a Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial

NCT06908642 is registered in ClinicalTrials.gov with Anhui Hemay Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT06908642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06908642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety of Hemay005 Tablets in Multiple Doses and Different Administration Methods in Multiple Administrations for Chinese Adult Healthy Subjects in a Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial
Lead sponsor
Anhui Hemay Pharmaceutical Co., Ltd
Phase
Phase 1
Overall status
Completed
Start date
December 25, 2024
Completion date
June 3, 2025
Enrollment
468 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease